NADF Fludrocortisone Acetate Follow-up Survey

Many were affected by a recent shortage of fludrocortisone acetate, a medication taken daily by patients whose adrenal glands do not produce aldosterone. The shortage occurred when Teva Pharmaceuticals stopped manufacturing this vital medication last fall. There are only two companies that produce fludrocortisone for the US market, Teva Pharmaceutical and Impax/Amneal.  To resolve this situation, Impax/Amneal is increasing production of fludrocortisone to meet the demand and Teva is in the process of starting the production again with projected resupply in mid-April 2019.

This follow-up survey will help us assess whether the increase in production is working effectively.

Question Title

* 1. When did you receive your last order of fludrocortisone acetate?

Date

Question Title

* 2. Did you experience any issues or delays with this most recent order?

Question Title

* 3. Due to the shortage, have you switched from Teva to Impax/Amneal for your fludrocortisone prescription?

Question Title

* 4. Have you noticed any difference in effectiveness of the medication?

Question Title

* 5. Have you (with your doctor's consent) needed to make any adjustments after switching from Teva to Impax?

Question Title

* 6. Have you had any issues with insurance coverage with the most recent order?

Question Title

* 7. If you have had issues with insurance coverage, please provide details in the comment box, including the full name of your insurance and the issue you experienced. It will also help for you to provide your contact info in case we need more information to investigate.

Question Title

* 8. Are you currently without your fludrocortisone?

Question Title

* 9. In what state or U.S. territory do you live?

Question Title

* 10. If you are still unable to obtain fludrocortisone, NADF would like to help. Please provide your name and contact information in the space provided.

0 of 10 answered
 

T